Moreover, mutations in the SH2 and other regions of STAT3 are associated with increased tumor malignancy (Figure 1A) because they induce hyper-activation of the JAK/STAT pathway and resistance to dephosphorylation of STAT3 [24]. The gene discussed is STAT3; the disease is neoplasm.